Dr. Frederick R Aronson MD
Hematologist-Oncologist | Hematology & Oncology
100 Campus Dr Suite 108 Scarborough ME, 04074Rating
5/5
About
Dr. Frederick Aronson is a hematologist oncologist practicing in Scarborough, ME. Dr. Aronson specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Yale Univ Sch of Med, New Haven Ct 1980
Yale School of Medicine 1980
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The secondary response of chickens given a primary inoculation of bovine serum albumin at different ages.
- Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas.
- Gossypol effects on endothelial cells and tumor blood flow.
- Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.
- IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.
- Life-threatening bullous skin eruptions during interleukin-2 therapy.
- High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.
- Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects.
- Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
- Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia.
- Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells.
- Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens.
- Summary statistics and treatment decisions.
Treatments
- Pancreatic Cancer
- Prostate Cancer
- Melanoma
- Skin Cancer
- Bladder Cancer
- Kidney Cancer
- Lung Cancer
- Esophageal Cancer
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Thyroid Cancer
- Leukemia
- Testicular Cancer
- Extra Corporeal Shockwave Therapy
Dr. Frederick R Aronson MD's Practice location
Practice At 100 Campus Dr Suite 108
100 Campus Dr Suite 108 -Scarborough, ME 04074Get Direction
Dr. Frederick R Aronson MD's reviews
Write ReviewPatient Experience with Dr. Aronson
- Elizabeth b.
melanoma experience.
- E. b.
excellent experience.
Recommended Articles
![]()
This New Zealand Native Beat Cancer Eight TimesBeing diagnosed with cancer can be a world-shaking experience. Going through the necessary chemotherapy and radiation treatment to beat cancer can be a difficult struggle, but coming out cancer-free feels incredibly liberating.Maybe it’s that feeling of having beaten cancer that can make suffering...
![]()
Genetic Advancements in Lymphoma TreatmentCancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
![]()
Lymphoma News: Mother Gives Birth to Healthy Daughter after Chemo During PregnancyChemotherapy has a reputation for its not-so-great side effects. As many people know, chemotherapy is known to cause off target symptoms for most cancer patients such as nausea and vomiting, hair loss, and extreme fatigue. In addition to the symptoms that one may experience during treatment, some of...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
![]()
Morphos Declared a "Breakthrough Therapy" for LymphomaMorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
![]()
Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant RecipientsLymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
Nearby Providers
![]()
Dr. Chiara Battelli MD100 CAMPUS DR UNIT 108 SCARBOROUGH ME 04074![]()
Dr. Preston H Dalglish MD26 W Cole Rd Biddeford ME 04005![]()
Dr. Christian Anton Thomas MD100 CAMPUS DRIVE SCARBOROUGH ME 04074![]()
Dr. Devon L Evans MD100 Campus Dr Scarborough ME 04074![]()
Dr. Owen B Pickus D.O.2 Chabot St Westbrook ME 04092![]()
Dr. Helen F. Ryan MD100 Campus Dr Scarborough ME 04074
Nearest Hospitals
MERCY HOSPITALl
144 STATE STREET PORTLAND ME 4101MAINE MEDICAL CENTERl
22 BRAMHALL ST PORTLAND ME 4102SOUTHERN MAINE HEALTH CAREl
1 MEDICAL CENTER DRIVE BIDDEFORD ME 4005